170 related articles for article (PubMed ID: 15591116)
21. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
22. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
23. Cross-linking of membrane IgM on B CLL cells.
Grillot-Courvalin C; Hivroz C; Brouet JC
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):301-4. PubMed ID: 3146745
[TBL] [Abstract][Full Text] [Related]
24. Aberrant trafficking of the B cell receptor Ig-alpha beta subunit in a B lymphoma cell line.
Condon C; Hourihane SL; Dang-Lawson M; Escribano J; Matsuuchi L
J Immunol; 2000 Aug; 165(3):1427-37. PubMed ID: 10903747
[TBL] [Abstract][Full Text] [Related]
25. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
[TBL] [Abstract][Full Text] [Related]
26. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
27. B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.
Tkachenko A; Kupcova K; Havranek O
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203179
[TBL] [Abstract][Full Text] [Related]
28. B cell receptor accessory molecule CD79 gets involved in response against Streptococcus agalactiae infection and BCR signaling in Nile tilapia (Oreochromis niloticus).
Wu L; Bian X; Kong L; Yin X; Mu L; Wu S; Gao A; Wei X; Guo Z; Ye J
Fish Shellfish Immunol; 2019 Apr; 87():212-219. PubMed ID: 30648625
[TBL] [Abstract][Full Text] [Related]
29. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
Vire B; David A; Wiestner A
J Immunol; 2011 Oct; 187(8):4040-50. PubMed ID: 21908732
[TBL] [Abstract][Full Text] [Related]
30. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
Thompson AA; Do HN; Saxon A; Wall R
Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells.
Hashimoto S; Chiorazzi N; Gregersen PK
Mol Immunol; 1995 Jun; 32(9):651-9. PubMed ID: 7643857
[TBL] [Abstract][Full Text] [Related]
32. IL-4 enhances expression and function of surface IgM in CLL cells.
Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
[TBL] [Abstract][Full Text] [Related]
33.
Coulter EM; Pepper A; Mele S; Folarin N; Townsend W; Cuthill K; Phillips EH; Patten PEM; Devereux S
Haematologica; 2018 Mar; 103(3):497-505. PubMed ID: 29242301
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms that control expression of the B lymphocyte antigen receptor complex.
Grupp SA; Mitchell RN; Schreiber KL; McKean DJ; Abbas AK
J Exp Med; 1995 Jan; 181(1):161-8. PubMed ID: 7807000
[TBL] [Abstract][Full Text] [Related]
35. The cytoplasmic domain of Ig alpha is necessary and sufficient to support efficient early B cell development.
Pike KA; Iacampo S; Friedmann JE; Ratcliffe MJ
J Immunol; 2004 Feb; 172(4):2210-8. PubMed ID: 14764688
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
37. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia.
Minici C; Gounari M; Übelhart R; Scarfò L; Dühren-von Minden M; Schneider D; Tasdogan A; Alkhatib A; Agathangelidis A; Ntoufa S; Chiorazzi N; Jumaa H; Stamatopoulos K; Ghia P; Degano M
Nat Commun; 2017 Jun; 8():15746. PubMed ID: 28598442
[TBL] [Abstract][Full Text] [Related]
38. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
39. Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b.
Seon BK; Okazaki M; Duzen J; Matsuno F; Goey AKL; Maguire O
Leuk Res; 2024 Jan; 136():107436. PubMed ID: 38232613
[TBL] [Abstract][Full Text] [Related]
40. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
Guarini A; Chiaretti S; Tavolaro S; Maggio R; Peragine N; Citarella F; Ricciardi MR; Santangelo S; Marinelli M; De Propris MS; Messina M; Mauro FR; Del Giudice I; Foà R
Blood; 2008 Aug; 112(3):782-92. PubMed ID: 18487510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
